2018
DOI: 10.1016/j.biopha.2018.03.106
|View full text |Cite
|
Sign up to set email alerts
|

Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(35 citation statements)
references
References 39 publications
0
33
0
Order By: Relevance
“…The PI3K/Akt signaling pathway serves a role in cell growth and proliferation, and has been observed to be dysregulated in various cancer types ( 47 ). A previous study demonstrated that the PI3K/Akt signaling pathway is inactivated, whereas osthole promotes the apoptosis of esophageal squamous cell carcinoma ( 48 ). Furthermore, repression of the PI3K/Akt signaling pathway inhibits cell viability and may enhance the apoptosis of PCa ( 49 ), indicating the role of the PI3K/Akt signaling pathway during tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…The PI3K/Akt signaling pathway serves a role in cell growth and proliferation, and has been observed to be dysregulated in various cancer types ( 47 ). A previous study demonstrated that the PI3K/Akt signaling pathway is inactivated, whereas osthole promotes the apoptosis of esophageal squamous cell carcinoma ( 48 ). Furthermore, repression of the PI3K/Akt signaling pathway inhibits cell viability and may enhance the apoptosis of PCa ( 49 ), indicating the role of the PI3K/Akt signaling pathway during tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…Besides, osthole could also influence the cell growth circle to induce apoptosis at the G2/M phase via the caspase signaling pathway [188]. Osthole suppressed the clonogenicity of esophageal cell carcinomas (ESCC) cells such as KYSE150 and KYSE410 cells in a dose-dependent manner, plus, it was also noticed that osthole's inhibitory effect against ESCC cells was related to the build-up of cell cycle progression at G2/M phase and apoptosis induction with the activation of caspase-dependent pathway, the P13K/AKT (p-AKT) signaling pathway through the activation of PTEN which was responsible for P13K/AKT pathway negative regulation and cell growth inhibition [189]. For pancreatic cancer, osthole could inhibit pancreatic cancer progression, reduce tumor weight, suppress proliferation, migration, and cause apoptosis of pancreatic 02 cells.…”
Section: Digestive System Cancermentioning
confidence: 98%
“…In vitro [176] Anti-osteoporosis effect Osthole 1 × 10 −4 , 1 × 10 −5 , 1 × 10 −6 , 1 × 10 −7 mol/L. In vitro [177] Anti-osteoporosis effect Osthole 0, 6.25, 12.5, 25, 50 µmol/L In vitro [178] Anti-osteoporosis effect Bone-targeted osthole 10 −4 , 10 −5 , 10 −6 , 10 −7 mmol/L In vitro [179] Anti-osteoporosis effect Osthole 100, 50, 25 µmol/L In vitro [180] Anti-osteoporosis effect Osthole 1 × 10 −5 mol/L In vitro [181] Anti-osteoporosis effect Osthole 10 −5 mol/L In vitro [182] Anti-osteoporosis effect Bone-targeted Osthole 10 −5 mol/L In vitro [183] Anti-osteoporosis effect Osthole 10 −7 , 10 −6 , 10 −5 , and 10 −4 mol/L In vitro [184] Anti-osteoporosis effect Gushudan, a chinese herbal formula with CMC 30 g/kg per day for 12 weeks via oral administration In vivo [185] Bone fracture healing effect Osthole 20 mg/kg for 1, 2, 3 weeks among 3 groups via oral gavage In vivo+ In vitro [186] Anti-osteoporosis effect Total flavonoids 5 mL/kg per day for 90 days In vivo [187] Anti-osteoporosis effect Osthole 10 mg/kg per day for 5 days via subcutaneous injection In vivo [188] Anti-periodontitis effect Osthole 10 −4 , 10 −5 , 10 −6 , and 10 −7 m/L for 3 days In vivo+ In vitro [189] Anti-cancer effect Osthole 0.05, 0.1, 0.15 mmol/L In vitro [190] Anti-cancer effect Osthole 0, 20, 40, 80, 120, 160, 200 µM In vitro [191] Anti-cancer effect Osthole 0, 20, 80, and 160 µM for 14 days intraperitoneal injection In vivo+ In vitro [192] Table A1. Cont.…”
Section: Pharmacological Effects Tested Substance Active Dose/concentmentioning
confidence: 99%
“…All experiments were repeated at least 3 times and the data were presented as the mean ± standard deviation (SD). The results were analyzed by Student's t-test for the comparison of two and ANOVA (followed by Tukey's post hoc test) for the comparison of multiple samples using SPSS 19.0 software (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant result.…”
Section: Real-time Reverse Transcription-quantitative Polymerase Chaimentioning
confidence: 99%
“…PTEN is a tumor suppressor gene that has frequently been reported to be involved in the regulation of cell proliferation, invasion, migration and apoptosis in many types of cancer, and the expression of PTEN is downregulated in a wide range of malignancies, including breast cancer, glioblastoma, colorectal carcinoma, pancreatic cancer and OSCC (13)(14)(15)(16)(17). Previous studies have demonstrated that the PI3K/Akt signaling pathway is involved in multiple biological processes and that PTEN functions as a tumor suppressor by negatively regulating the PI3K/Akt signaling pathway, which reduces cell growth and increases cell apoptosis (18,19). miRNAs, including miR-136, miR-181a and miR-221/222, have been reported to regulate the expression of PTEN (20)(21)(22).…”
Section: Introductionmentioning
confidence: 99%